Abstract
In patients suffering from cancer, pain is the most prevalent symptom and often indicates a progression of the disease. Following some basic principles in most patients sufficient pain relief can be achieved. After determination of the pain diagnosis the treatment should be conducted according to the WHO pain guidelines. Drug intervals should consider the duration of the drug effect. Prophylaxis of possible side effects is a further cornerstone of a successful treatment. The following article will provide an overview on principles and new developments of cancer pain management.
Literatur
-
1
Fallon M, Hanks G, Cherny N.
Principles of control of cancer pain.
BMJ.
2006;
332
1022-1024
-
2 Melzack R, Katz J. Pain assessment in adult patients. In: McMahon SB, Koltzenburg M (eds) Wall and Melzack's Textbook of Pain, 5th ed. London; Elsevier Churchill Livingstone 2006: 291-304
-
3 World Health Organisation .Cancer pain relief. Genf; World Health Organisation 1986
-
4
Edwards J E, McQuay H J.
Dipyrone and agranulocytosis: what is the risk?.
Lancet.
2002;
360
1438
-
5
Hanks G W, Conno F, Cherny N. et al .
Morphine and alternative opioids in cancer pain: the EAPC recommendations.
Br J Cancer.
2001;
84
587
-
6 World Health Organisation .Cancer pain relief: with a guide to opioid availability. Genf; World Health Organisation 1996
-
7
Nauck F, Ostgathe C, Dickerson E D.
A German model for methadone conversion.
Am J Hosp Palliat Care.
2001;
18 (3)
200-202
-
8
Mercadante S, Radbruch L, Caraceni A. et al .
Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care.
Cancer.
2002;
94
832
-
9
Radbruch L, Nauck F.
Morphine and alternative opioids in cancer pain: the EAPC recommendations.
Schmerz.
2002;
16
186
-
10
Nauck F.
Symptomkontrolle in der Finalphase.
Schmerz.
2001;
15
362-369
-
11 Nauck F, Radbruch R. Systemische medikamentöse Schmerztherapie. In: Aulbert E, Nauck F, Radbruch R (Hrsg) Lehrbuch der Palliativmedizin. Stuttgart; Schattauer 2007: 176-207
Dr. med. Christoph Ostgathe
Klinik und Poliklinik für Palliativmedizin, Universitätsklinikum Köln
Kerpener Straße 62
50924 Köln
eMail: christoph.ostgathe@uk-koeln.de
